Loading...
XNAS:TMDX
TransMedics shares are trading higher after the company reported a 38% increase in revenue for Q2 2025 and raised its full-year revenue guidance.
TransMedics shares are trading higher after the company reported a 48% year-over-year increase in Q1 revenue and raised its full-year 2025 revenue guidance.